Asim Muhammad, Zaidi Alia, Ghafoor Tariq, Qureshi Yasir
Department of Paediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
J Pak Med Assoc. 2011 Jul;61(7):666-70.
To analyze the common causes of death in childhood Acute Lymphoblastic Leukaemia (ALL) patients during therapy at Paediatric Oncology Department of Shaukat Khanum Memorial Cancer Hospital.
Retrospective descriptive study conducted at Paediatric Oncology department at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore Pakistan. All registered cases of ALL from 12 months to 18 years of age who expired between May 2001 to December 2005 were included. Mortality data was collected and analyzed regarding age, sex, WBC count, immunophenotype, treatment protocol, remission, and timing of death with respect to treatment protocol and the cause of death.
Out of 304 new cases of ALL registered in the study period, 74 (24%) died during treatment. During induction 39 of 74 (52.7%) died, 33 (44.5%) in first remission and 2 (2.8%) before initiation of therapy. Infection alone or in combination with other factors was responsible for deaths in 63 of 74 (85%) cases. Septicemia, pulmonary and gastrointestinal infections were documented in 37/63 (58.7%), 44/63 (69%) and 8/63 (12.6%) cases respectively. Eight (10.8%) died due to haemorrhage. Three (4%) deaths were secondary to chemotherapy induced toxicity.
Infection is the major cause of mortality in ALL patients in our study population. To improve survival it is imperative to improve supportive care especially prevention and management of infection.
分析在巴基斯坦拉合尔市绍卡特汗姆纪念癌症医院儿科肿瘤科接受治疗的儿童急性淋巴细胞白血病(ALL)患者的常见死因。
在巴基斯坦拉合尔市绍卡特汗姆纪念癌症医院及研究中心的儿科肿瘤科进行回顾性描述性研究。纳入2001年5月至2005年12月期间所有登记的12个月至18岁的ALL死亡病例。收集并分析了有关年龄、性别、白细胞计数、免疫表型、治疗方案、缓解情况以及相对于治疗方案的死亡时间和死因的死亡率数据。
在研究期间登记的304例ALL新病例中,74例(24%)在治疗期间死亡。诱导期死亡74例中的39例(52.7%),首次缓解期死亡33例(44.5%),治疗开始前死亡2例(2.8%)。74例中有63例(85%)的死亡单独由感染或与其他因素共同导致。分别有37/63(58.7%)、44/63(69%)和8/63(12.6%)的病例记录有败血症、肺部和胃肠道感染。8例(10.8%)死于出血。3例(4%)死亡继发于化疗引起的毒性反应。
在我们的研究人群中,感染是ALL患者死亡的主要原因。为提高生存率,必须改善支持性护理,尤其是感染的预防和管理。